文献速递中医妇科中药与中成药合理使用

中药联合来曲唑治疗多囊卵巢综合征有效性的Meta分析

Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: a meta-analysis.
PubMed 文献 · J Integr Med · 2017-01-01

本Meta分析比较中药联合来曲唑与单用来曲唑治疗多囊卵巢综合征的疗效。共纳入8项随机对照试验、537例患者。结果显示联合治疗在周期排卵率、妊娠率和症状治疗总有效率上均高于单药治疗,且LH/FSH比值和体重指数更低,但两组LH和FSH水平无统计学差异。结论认为联合治疗可能更有效。

要点

  • 中药联合来曲唑可提高PCOS患者的周期排卵率和妊娠率。
  • 联合治疗的症状治疗总有效率高于来曲唑单药治疗。
  • 联合治疗组LH/FSH比值和BMI更低,但LH、FSH水平无统计学差异。

核心结论

  • 现有证据表明中药联合来曲唑治疗PCOS比来曲唑单药治疗更有效。

研究设计与样本

  • 系统检索PubMed、Cochrane Library、中国生物医学文献数据库、中国知网和万方数据,并手工检索未电子化相关文献。
  • 纳入比较中药联合来曲唑与来曲唑单药治疗PCOS女性的随机对照试验,PCOS定义为无排卵、生化或临床高雄激素血症及多囊卵巢。
  • 共纳入8项RCT,涉及537例患者;由两名独立评价者提取数据并按Cochrane手册评估偏倚风险。

主要发现

  • 联合治疗组的周期排卵率、妊娠率和症状治疗总有效率均高于来曲唑单药组。
  • 联合治疗组LH/FSH比值和体重指数低于来曲唑单药组。
  • 两组间LH和FSH水平未发现统计学差异。

临床怎么用

  • 对于PCOS患者,可考虑在来曲唑基础上联合中药治疗以改善排卵和妊娠结局。
  • 联合治疗可能有助于降低LH/FSH比值和体重指数,但需结合患者具体情况评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polycystic ovary syndrome (PCOS) is an endocrine disease that affects gynecological health. Treatment of PCOS remains a big challenge for clinicians. OBJECTIVE: This meta-analysis was developed to compare the efficacy of co-treatment with traditional Chinese medicine (TCM) and letrozole against letrozole monotherapy in the treatment of PCOS. SEARCH STRATEGY: Randomized controlled trials (RCTs) were electronically retrieved from PubMed, Cochrane Library, China Biomedical Literature Database, China National Knowledge Infrastructure and Wanfang Data; related papers that were not available electronically were manually checked. All papers were assessed according to the Cochrane Handbook for Systematic Reviews of Interventions and the valid data were analyzed using Revman software (The Cochrane Collaboration, Copenhagen, Denmark). INCLUSION CRITERIA: We included RCTs that compared co-treatment with TCM and letrozole against letrozole monotherapy in women with PCOS, which was defined by anovulation, biochemical or clinical hyperandrogenemia and polycystic ovaries. We included trials from all sources. DATA EXTRACTION AND ANALYSIS: Two independent reviewers extracted data, and evaluated study quality according to the Cochrane Handbook for Systematic Reviews of Interventions criteria for RCT, including issues of patient randomization, blinding and bias. RESULTS: Eight RCTs, involving a total of 537 patients, were included in the present study. The meta-analysis showed that the cycle ovulation rate, the pregnancy rate and the total effective rate of symptom treatment were higher in treatments combining TCM with letrozole, compared with letrozole monotherapy. Although the rate of luteinizing hormone (LH)/follicle-stimulating hormone (FSH) and the body mass index of the group receiving combined therapy were lower than in letrozole monotherapy, no statistical difference was found in the LH and FSH level between the two groups. CONCLUSION: Available evidence showed that co-treatment with TCM and letrozole was more effective than letrozole monotherapy in the treatment of PCOS.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Ma QW, Tan Y. Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: a meta-analysis. J Integr Med. 2017. PMID: 28285614. doi:10.1016/S2095-4964(17)60320-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。